z-logo
open-access-imgOpen Access
Rash as a Prognostic Factor in West Nile Virus Disease
Author(s) -
Gregory Huhn,
Mark S. Dworkin
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/505606
Subject(s) - medicine , rash , west nile virus , virology , disease , virus , dermatology
Muto CA. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections (HAIs) using active MRSA surveillance cultures (MSC)— three-year follow-up [abstract 22]. In: Conference of the 15th Annual Society for Healthcare Epidemiology of America (Los Angeles, CA). 2005:64. 10. Huang SS, Yokoe DS, Rego VH, et al. Impact of ICU surveillance for MRSA on bacteremia [abstract 1074]. In: 43rd Annual Meeting of The Infectious Diseases Society of America (San Francisco, CA). 2005:237. 11. Sommer A. SARS: paradigm for an emerging pathogen in a global community. In: the opening plenary session of the Fourteenth Annual Meeting of The Society for Healthcare Epidemiology of America (Philadelphia, PA). 2004. 12. Beck-Sague CM, Dooley SW, Hutton MD, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992; 268: 1280–6. 13. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistantEnterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001; 22:140–7. 14. Christiansen KJ, Tibbett PA, Beresford W, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004; 25:384–90. 15) Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006; 42: 739–46. 16. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427–33. 17. Sunenshine RH, Liedtke LA, Fridkin SK, Strausbaugh LJ, Infectious Diseases Society of America Emerging Infections Network. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol 2005; 26:138–43. 18. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003; 24:322–6. 19. Karchmer TB, Jernigan LJ, Durbin LJ, Simonton BM, Farr BM. Eradication of MRSA colonization with different regimens [abstract 65]. In: the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America, (San Francisco, CA). 1999:42. 20. Boyce JM, Cookson B, Christiansen K, et al. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005; 5:653–63. 21. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362–86.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom